TOPIC

Biomedicine: Science

Related Topics:
Biomedicine: Companies
Biomedicine: Policy
Biomedicine: Science
Biomedicine: Industry Trends
Biomedicine: Geopolitics
Biomedicine: Science
Learn about China’s biomedical breakthroughs, from cutting-edge pharmaceuticals to life-saving research, driving global health innovation.
Four patients with spinal cord injuries were able to move their limbs hours after groundbreaking surgery as part of a clinical trial led by Shanghai’s Fudan University. Photo: Fudan University
Science

Chinese breakthrough challenges Elon Musk’s verdict on paralysed patients

Patients with spinal cord injuries have been offered the chance to walk again after the success of a Chinese trial.

videocam
19
Science

China-led team uses 3D-printed male sex organ for ED treatment in world first

videocam
Hong Kong

She tried several careers but found her niche in genetic sequencing

Cancer

Groundbreaking cancer therapies are the goal for this biotech innovator

PostMag talks to 5 women innovators at the top of their game and pushing the boundaries of scientific discovery: here we meet Gina Jiang, managing director of the Hong Kong Institute of Biotechnology.

Gina Jiang is managing director of the Hong Kong Institute of Biotechnology. Photo: TMT
Hong Kong science and tech

Round table: what can women in STEM do to lead change?

PostMag hosted a discussion between 5 Hong Kong-based innovators blazing a trail: Florence Chan, Angela Wu, Wendy Lam, Gina Jiang and Megan Lam.

Science

Chinese vaccine shows promise in stopping plaque build-up in arteries

In mice trial, experimental nanovaccine found to reduce development of condition that can lead to blood clots, stroke and heart attacks.

Advertisement
Advertisement
Advertisement
Mainland China

Hong Kong doctor bets on blood tests after saving mums from the needle

Lo’s blood tests can potentially reveal more information about patients’ health, from cancers to neurodegenerative conditions to age-related diseases.

Illustration by Henry Wong
China technology

Opinion | In tech war, China is gunning for mass adoption over premium innovation

From artificial intelligence and biotech to autonomous driving, China is disrupting the traditional high-cost model of proprietary innovation.

videocam
Science

Chinese scientists investigate whether microbe in food eases autism symptoms

Researchers say they are building on growing evidence that gut microbiota may influence brain function, mood and cognition.

videocam
Biomedicine: Companies

Hong Kong biotech start-up Alephoson eyes global trial for eye-drug delivery

Hong Kong biotech start-up works with university partners to conduct global clinical trials studying prevalent eye diseases.

Benjamin Lee, a founder and CEO of Alephoson. Photo: Edmond So
Biomedicine: Companies

CR Pharma, NAMI join forces to fight Alzheimer’s with Pfizer cancer drug

Palbociclib, developed by Pfizer for certain types of advanced breast cancer, was approved for sale in 2015.

Hong Kong’s Nano and Advanced Materials Institute. Photo: innovationhub.hk
Hong Kong economy

Opinion | Weakest link in Hong Kong’s tech ecosystem? Scale-up funding

With venture capital and IPO growth weak globally, start-ups should aggressively seek international commercialisation, leverage marketing strategies and connect with power players overseas.

videocam
New medical drugs

Novel drug awaits Hong Kong diabetics suffering from debilitating eye disease

Oculis’ OCS-01 eye drops, currently in phase 3 trials for diabetic macular edema, can be an alternative to injection, CEO says.

videocam
Biomedicine: Companies

Hong Kong residents reticent to get latest Covid-19 jab, Moderna survey finds

About 52 per cent of Hong Kong respondents said they were willing to get the updated vaccine, compared with 58 per cent in Singapore.

Moderna’s survey results indicate a “growing complacency” even as coronavirus variants continue to evolve. Photo: Shutterstock
Biomedicine: Companies

China welcomes new US$1 billion Sanofi project in Beijing

Sanofi’s latest capital outlay in China will cover the development of a new insulin plant in the nation’s capital.

Sanofi said the new plant in Beijing will be its fourth such facility on the mainland. Photo: Shutterstock
Biomedicine: Companies

Hong Kong start-up eyes global pest control market with scent-based products

Plasticvore is a two-year old biotech start-up offering alternative, humane solutions to controlling and eliminating pests, founder says.

videocam
SCMP Highlights

Recap | ‘Promising’ steps to HIV vaccine, Trump tariffs threaten profits: 5 biotech stories

Discover breakthroughs in the biotech world, from a potential HIV cure to China’s booming drug market and innovative coronavirus treatments, in some of our latest stories.

Advertisement
Advertisement
Advertisement
China society

China’s netizens warned that shutting down scientists’ views may hobble progress

Renowned scientists such as physicist He Zuoxiu and Fields Medal winner Yau Shing-Tung have been subjected to online attacks.

videocam
24
“Fandom culture is worryingly penetrating into discussions of science topics” and could hurt China’s technology sector, editorial in state-affiliated media outlet has warned. Photo: Shutterstock
Hong Kong

Vaccine shows promise in curing HIV, Hong Kong start-up says

‘We may be on the brink of a breakthrough,’ Dr Edward Leong, advisory board chairman of Immuno Cure says.

Biomedicine: Companies

Germany’s BioNTech buys Biotheus in US$800 million push into cancer drugs

BioNTech says deal will support its push into the development of cancer drugs using its proven mRNA technology.

Science

Opinion | Why a new approach to diabetes treatment is desperately needed

Current widely used treatment approaches are not fit for task as they ignore the idiosyncrasies in diabetes that can arise in each patient.

videocam
A diabetes patient injecting insulin in their abdomen. The International Diabetes Foundation estimates almost 540 million adults had diabetes in 2020. Photo: Shutterstock
Science

Will Chinese scientists make or break the uprising in academic publishing?

A new publishing model is causing ructions in academia, and it could be China who decides the winner.

videocam
7
A battle is under way in the acedemic publishing world after a journal database delisted a well-known life sciences journal over its new publishing model. Photo: Shutterstock
Health in China

Chinese pharmaceutical companies look abroad for growth markets

Shanghai Henlius struck a deal in Saudi Arabia while XtalPi signed a partnership with Sinar Mas Multiartha in Indonesia.

Science

China’s ‘bat lady’ Shi Zhengli opens path for new coronavirus research

Shi and a team of Chinese, US and Swiss researchers have developed a customised virus receptor that could pave way for new treatments.

videocam
8
Greater Bay Area

Hong Kong health-tech start-ups create digital wearables for seniors

With a regulatory approach that expands the market for such devices to the Greater Bay Area, local companies see opportunity for growth.

videocam
Senior Hongkongers exercise at Victoria Park in Causeway Bay. Photo: Dickson Lee
Biomedicine: Companies

Hong Kong health tech: private-public alliance advances male HPV testing

Neo-Health Group says its device, developed with a government-backed research institute, will also help test for skin infections and cancers.

The Nanoswab device viewed through an optical microscope. Photo: Handout
Cancer

CK Life’s Yuen banks on Big Pharma experience to boost new drug success

Lance Yuen spent two decades at Bristol Myers Squibb and Bayer in the region before becoming the CEO at CK Life Sciences last month.

Nobel Prize

Video | Nobel Prize winners recognised for ‘groundbreaking’ microRNA discovery

Advertisement
Advertisement
Advertisement
Help preserve 120 years of quality journalism.
SUPPORT NOW
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement